Clinical Trial Update: Sorafenib for Patients With Extensive Keloids [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating sorafenib for patients with extensive keloids was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keloids

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: Tirgan, Michael H., M.D. | Conditions: Keloids | Phase 2 | Status: TERMINATED